Revlimid (Celgene Corporation)
Welcome to the PulseAid listing for the Revlimid drug offered from Celgene Corporation. This Thalidomide Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Celgene Corporation |
NON-PROPRIETARY NAME: | Lenalidomide |
SUBSTANCE NAME: | LENALIDOMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Thalidomide Analog [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-04-16 |
END MARKETING DATE: | 0000-00-00 |
Revlimid HUMAN PRESCRIPTION DRUG Details:
Item Description | Revlimid from Celgene Corporation |
LABELER NAME: | Celgene Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.5(mg/1) |
START MARKETING DATE: | 2012-04-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 59572-402_95a0b71b-69ee-4067-9580-4f89fcdd377b |
PRODUCT NDC: | 59572-402 |
APPLICATION NUMBER: | NDA021880 |
Other LENALIDOMIDE Pharmaceutical Manufacturers / Labelers: